Share Price and Basic Stock Data
Last Updated: December 27, 2025, 10:10 pm
| PEG Ratio | 7.25 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Timken India Ltd operates within the bearings industry and has demonstrated a robust revenue growth trajectory over recent years. The company reported total sales of ₹2,807 Cr for the fiscal year ending March 2023, reflecting a notable increase from ₹2,203 Cr in the previous year. This upward trend continued into the trailing twelve months (TTM), where sales stood at ₹3,193 Cr, indicating successful market penetration and demand for its products. Quarterly sales data reveals fluctuations, with a peak of ₹898 Cr in March 2024, followed by ₹940 Cr projected for March 2025. This suggests a strong recovery and growth potential, despite some seasonal variations. The company’s revenue growth is further supported by an operating profit margin (OPM) of 18%, which aligns well with industry standards, indicating efficient operations. With a total of 76,566 shareholders, Timken India has successfully maintained a healthy market presence, positioning itself as a key player in the bearings sector.
Profitability and Efficiency Metrics
Timken India Ltd’s profitability metrics reflect a strong operational performance, underscored by a net profit of ₹455 Cr for the TTM period. The company’s return on equity (ROE) stood at 17%, while return on capital employed (ROCE) reached 20.9%, showcasing effective utilization of shareholder funds and capital. The operating profit for the fiscal year ending March 2025 is projected to be ₹592 Cr, with a profit before tax of ₹553 Cr, further emphasizing the company’s robust profitability landscape. The net profit margin stood at 14.21% for March 2025, indicating effective cost management and pricing strategies. Additionally, the interest coverage ratio of 149.64x reflects the company’s strong ability to meet its interest obligations, underscoring financial stability. The cash conversion cycle (CCC) of 129 days is relatively efficient, demonstrating the company’s ability to convert investments in inventory and receivables into cash flows in a timely manner.
Balance Sheet Strength and Financial Ratios
Timken India Ltd’s balance sheet exhibits significant strength, with total assets reported at ₹3,425 Cr and total liabilities at ₹3,425 Cr as of March 2025. The company has maintained minimal borrowings, with total borrowings recorded at merely ₹15 Cr, reflecting a debt-free status that enhances its financial resilience. The equity capital has remained stable at ₹75 Cr, while reserves have grown to ₹2,770 Cr, indicating substantial retained earnings and financial health. The price-to-book value (P/BV) ratio is reported at 7.27x, suggesting that the stock is trading at a premium compared to its book value, which may indicate investor confidence in future growth prospects. Furthermore, the current ratio of 3.82x indicates robust liquidity, providing a cushion for short-term obligations. The company’s efficiency is further highlighted by an asset turnover ratio of 0.98%, demonstrating effective asset utilization to generate revenue.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Timken India Ltd indicates a diverse investor base, with promoters holding 51.05% of the shares, a decline from 67.80% in December 2022. This reduction suggests a potential dilution of control, though it may also reflect a strategic move to attract institutional investors. Foreign institutional investors (FIIs) have increased their stake to 7.39% from 4.30% in December 2022, while domestic institutional investors (DIIs) have seen their holdings rise to 29.72%. This growing institutional interest signals a positive outlook from professional investors regarding the company’s fundamentals. The public holding stands at 11.84%, showing a healthy distribution of shares among retail investors. With a total of 76,566 shareholders, the company attracts considerable retail interest, which is crucial for maintaining liquidity in the stock. Overall, the diverse shareholder composition reflects confidence in Timken India’s long-term growth potential.
Outlook, Risks, and Final Insight
Looking ahead, Timken India Ltd is poised for continued growth, supported by a strong product portfolio and increasing demand in the bearings sector. However, potential risks include fluctuations in raw material prices and global economic uncertainties that could impact production costs and demand stability. Additionally, the recent decline in promoter shareholding may raise concerns about long-term strategic direction. Nonetheless, with a solid financial foundation, marked by low debt and high profitability ratios, the company is well-positioned to navigate these challenges. If the company can effectively manage its operational efficiencies and maintain its market position, it could capitalize on growth opportunities in both domestic and international markets. Conversely, failure to adapt to market dynamics or manage costs effectively could hinder its growth trajectory. Overall, Timken India’s strengths in profitability and balance sheet resilience provide a favorable outlook, contingent upon strategic management of identified risks.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Galaxy Bearings Ltd | 156 Cr. | 490 | 1,125/474 | 25.5 | 337 | 0.00 % | 16.1 % | 13.6 % | 10.0 |
| Deccan Bearings Ltd | 404 Cr. | 202 | 202/81.2 | 8.79 | 0.00 % | 107 % | 107 % | 10.0 | |
| Benara Bearings & Pistons Ltd | 16.7 Cr. | 9.41 | 24.4/9.30 | 4.73 | 0.00 % | 26.1 % | 512 % | 10.0 | |
| Austin Engineering Company Ltd | 46.1 Cr. | 133 | 206/128 | 10.6 | 198 | 0.00 % | 8.04 % | 6.00 % | 10.0 |
| Timken India Ltd | 22,475 Cr. | 2,988 | 3,576/2,200 | 49.4 | 368 | 1.20 % | 20.9 % | 17.0 % | 10.0 |
| Industry Average | 13,504.57 Cr | 1,087.27 | 29.44 | 216.54 | 0.69% | 29.53% | 80.37% | 7.22 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 699 | 695 | 609 | 803 | 718 | 682 | 612 | 898 | 784 | 753 | 671 | 940 | 809 |
| Expenses | 528 | 563 | 506 | 650 | 582 | 546 | 510 | 699 | 643 | 620 | 565 | 730 | 666 |
| Operating Profit | 172 | 132 | 104 | 153 | 136 | 136 | 102 | 199 | 141 | 133 | 107 | 210 | 142 |
| OPM % | 25% | 19% | 17% | 19% | 19% | 20% | 17% | 22% | 18% | 18% | 16% | 22% | 18% |
| Other Income | 11 | 22 | 14 | 7 | 9 | 10 | 11 | 11 | 12 | 12 | 13 | 14 | 10 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 22 | 22 | 22 | 21 | 21 | 21 | 21 | 22 | 22 | 21 | 21 | 21 | 21 |
| Profit before tax | 160 | 131 | 95 | 137 | 123 | 124 | 91 | 187 | 130 | 124 | 98 | 202 | 130 |
| Tax % | 26% | 26% | 26% | 24% | 27% | 25% | 26% | 24% | 26% | 27% | 24% | 7% | 20% |
| Net Profit | 118 | 98 | 71 | 105 | 90 | 93 | 68 | 141 | 96 | 90 | 74 | 187 | 104 |
| EPS in Rs | 15.70 | 12.98 | 9.38 | 13.89 | 11.98 | 12.37 | 8.98 | 18.80 | 12.80 | 11.96 | 9.88 | 24.84 | 13.86 |
Last Updated: August 1, 2025, 10:10 am
Below is a detailed analysis of the quarterly data for Timken India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 809.00 Cr.. The value appears to be declining and may need further review. It has decreased from 940.00 Cr. (Mar 2025) to 809.00 Cr., marking a decrease of 131.00 Cr..
- For Expenses, as of Jun 2025, the value is 666.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 730.00 Cr. (Mar 2025) to 666.00 Cr., marking a decrease of 64.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 142.00 Cr., marking a decrease of 68.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 18.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 130.00 Cr.. The value appears to be declining and may need further review. It has decreased from 202.00 Cr. (Mar 2025) to 130.00 Cr., marking a decrease of 72.00 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be increasing, which may not be favorable. It has increased from 7.00% (Mar 2025) to 20.00%, marking an increase of 13.00%.
- For Net Profit, as of Jun 2025, the value is 104.00 Cr.. The value appears to be declining and may need further review. It has decreased from 187.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 83.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.86. The value appears to be declining and may need further review. It has decreased from 24.84 (Mar 2025) to 13.86, marking a decrease of 10.98.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 719 | 926 | 1,042 | 1,056 | 1,233 | 1,664 | 1,618 | 1,411 | 2,203 | 2,807 | 2,910 | 3,148 | 3,193 |
| Expenses | 646 | 792 | 880 | 898 | 1,070 | 1,375 | 1,254 | 1,159 | 1,692 | 2,246 | 2,337 | 2,556 | 2,596 |
| Operating Profit | 73 | 134 | 162 | 158 | 163 | 289 | 363 | 252 | 511 | 560 | 572 | 592 | 597 |
| OPM % | 10% | 14% | 16% | 15% | 13% | 17% | 22% | 18% | 23% | 20% | 20% | 19% | 19% |
| Other Income | 10 | 6 | 3 | 10 | 21 | 16 | 23 | 20 | 14 | 53 | 41 | 50 | 47 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 3 | 4 | 4 | 4 |
| Depreciation | 16 | 17 | 22 | 29 | 43 | 79 | 77 | 75 | 84 | 87 | 85 | 85 | 89 |
| Profit before tax | 66 | 122 | 142 | 138 | 140 | 224 | 306 | 195 | 438 | 524 | 524 | 553 | 550 |
| Tax % | 32% | 34% | 35% | 30% | 34% | 34% | 20% | 27% | 25% | 25% | 25% | 19% | |
| Net Profit | 45 | 81 | 92 | 97 | 92 | 149 | 246 | 143 | 327 | 391 | 392 | 447 | 455 |
| EPS in Rs | 6.58 | 11.87 | 13.50 | 14.29 | 13.53 | 19.76 | 32.72 | 19.04 | 43.49 | 51.95 | 52.13 | 59.48 | 60.47 |
| Dividend Payout % | 99% | 25% | 7% | 7% | 7% | 5% | 153% | 8% | 3% | 3% | 5% | 61% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 80.00% | 13.58% | 5.43% | -5.15% | 61.96% | 65.10% | -41.87% | 128.67% | 19.57% | 0.26% | 14.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.42% | -8.15% | -10.59% | 67.11% | 3.14% | -106.97% | 170.54% | -109.10% | -19.32% | 13.77% |
Timken India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 13% |
| 3 Years: | 11% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | -4% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 4, 2025, 2:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 68 | 68 | 68 | 68 | 68 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| Reserves | 314 | 370 | 462 | 550 | 634 | 1,266 | 1,501 | 1,268 | 1,582 | 1,962 | 2,342 | 2,770 | 2,693 |
| Borrowings | 3 | 3 | 4 | 8 | 16 | 23 | 24 | 35 | 32 | 31 | 25 | 17 | 15 |
| Other Liabilities | 114 | 144 | 168 | 251 | 261 | 411 | 377 | 510 | 505 | 489 | 545 | 564 | 598 |
| Total Liabilities | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,382 |
| Fixed Assets | 97 | 107 | 137 | 231 | 251 | 795 | 748 | 818 | 860 | 843 | 853 | 809 | 1,265 |
| CWIP | 26 | 27 | 21 | 58 | 54 | 64 | 157 | 97 | 50 | 53 | 104 | 592 | 241 |
| Investments | 23 | 17 | 38 | 91 | 55 | 176 | 13 | 0 | 99 | 236 | 161 | 117 | 120 |
| Other Assets | 354 | 435 | 506 | 498 | 619 | 741 | 1,060 | 973 | 1,185 | 1,424 | 1,870 | 1,908 | 1,756 |
| Total Assets | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,382 |
Below is a detailed analysis of the balance sheet data for Timken India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 75.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 75.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,693.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,770.00 Cr. (Mar 2025) to 2,693.00 Cr., marking a decrease of 77.00 Cr..
- For Borrowings, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 17.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 598.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 564.00 Cr. (Mar 2025) to 598.00 Cr., marking an increase of 34.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,382.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,425.00 Cr. (Mar 2025) to 3,382.00 Cr., marking a decrease of 43.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,265.00 Cr.. The value appears strong and on an upward trend. It has increased from 809.00 Cr. (Mar 2025) to 1,265.00 Cr., marking an increase of 456.00 Cr..
- For CWIP, as of Sep 2025, the value is 241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 592.00 Cr. (Mar 2025) to 241.00 Cr., marking a decrease of 351.00 Cr..
- For Investments, as of Sep 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 117.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,756.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,908.00 Cr. (Mar 2025) to 1,756.00 Cr., marking a decrease of 152.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,382.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,425.00 Cr. (Mar 2025) to 3,382.00 Cr., marking a decrease of 43.00 Cr..
Notably, the Reserves (2,693.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 131.00 | 158.00 | 150.00 | 147.00 | 266.00 | 339.00 | 217.00 | 479.00 | 529.00 | 547.00 | 575.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 69 | 68 | 66 | 66 | 66 | 66 | 96 | 89 | 75 | 82 | 81 |
| Inventory Days | 112 | 110 | 108 | 111 | 121 | 125 | 124 | 171 | 171 | 125 | 142 | 124 |
| Days Payable | 60 | 57 | 65 | 92 | 97 | 92 | 92 | 156 | 100 | 76 | 82 | 76 |
| Cash Conversion Cycle | 128 | 122 | 110 | 85 | 90 | 99 | 98 | 112 | 160 | 124 | 142 | 129 |
| Working Capital Days | 104 | 98 | 91 | 70 | 96 | 80 | 74 | 86 | 117 | 102 | 111 | 107 |
| ROCE % | 19% | 30% | 30% | 24% | 21% | 22% | 21% | 13% | 29% | 28% | 23% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 2,193,640 | 0.75 | 691.96 | 2,150,287 | 2025-12-14 00:38:48 | 2.02% |
| HDFC Small Cap Fund | 1,715,839 | 1.42 | 541.24 | 1,635,876 | 2025-12-14 13:37:58 | 4.89% |
| Nippon India Small Cap Fund | 1,184,218 | 0.54 | 373.55 | 1,134,218 | 2025-11-02 18:14:38 | 4.41% |
| Mirae Asset Large Cap Fund | 805,394 | 0.61 | 254.05 | 682,131 | 2025-10-30 01:21:09 | 18.07% |
| Nippon India Multi Cap Fund | 765,286 | 0.48 | 241.4 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 646,271 | 0.48 | 203.86 | N/A | N/A | N/A |
| Mirae Asset ELSS Tax Saver Fund | 584,528 | 0.68 | 184.38 | 469,585 | 2025-12-15 00:57:48 | 24.48% |
| SBI Large & Midcap Fund | 560,000 | 0.48 | 176.65 | 595,174 | 2025-10-30 01:21:09 | -5.91% |
| ICICI Prudential Smallcap Fund | 522,836 | 1.95 | 164.92 | 520,855 | 2025-12-14 01:36:52 | 0.38% |
| Invesco India Contra Fund | 480,033 | 0.74 | 151.42 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Diluted EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Cash EPS (Rs.) | 70.75 | 63.46 | 63.54 | 54.70 | 28.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Dividend / Share (Rs.) | 36.00 | 2.50 | 1.50 | 1.50 | 1.50 |
| Revenue From Operations / Share (Rs.) | 418.49 | 386.81 | 373.13 | 292.91 | 187.52 |
| PBDIT / Share (Rs.) | 85.32 | 81.52 | 81.57 | 69.79 | 36.08 |
| PBIT / Share (Rs.) | 74.05 | 70.19 | 69.97 | 58.58 | 26.12 |
| PBT / Share (Rs.) | 73.48 | 69.69 | 69.60 | 58.25 | 25.93 |
| Net Profit / Share (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| PBDIT Margin (%) | 20.38 | 21.07 | 21.86 | 23.82 | 19.23 |
| PBIT Margin (%) | 17.69 | 18.14 | 18.75 | 19.99 | 13.93 |
| PBT Margin (%) | 17.55 | 18.01 | 18.65 | 19.88 | 13.82 |
| Net Profit Margin (%) | 14.21 | 13.47 | 13.92 | 14.84 | 10.15 |
| Return on Networth / Equity (%) | 15.72 | 16.22 | 19.18 | 19.74 | 10.65 |
| Return on Capital Employeed (%) | 19.11 | 20.99 | 24.71 | 25.06 | 13.54 |
| Return On Assets (%) | 13.06 | 13.12 | 15.28 | 14.91 | 7.58 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 0.98 | 1.05 | 1.18 | 1.08 | 0.72 |
| Current Ratio (X) | 3.82 | 3.91 | 3.77 | 2.89 | 2.16 |
| Quick Ratio (X) | 2.56 | 2.50 | 2.44 | 1.61 | 1.32 |
| Inventory Turnover Ratio (X) | 4.80 | 4.71 | 1.64 | 1.58 | 1.36 |
| Dividend Payout Ratio (NP) (%) | 4.20 | 2.87 | 2.88 | 3.44 | 262.63 |
| Dividend Payout Ratio (CP) (%) | 3.53 | 2.36 | 2.36 | 2.74 | 172.44 |
| Earning Retention Ratio (%) | 95.80 | 97.13 | 97.12 | 96.56 | -162.63 |
| Cash Earning Retention Ratio (%) | 96.47 | 97.64 | 97.64 | 97.26 | -72.44 |
| Interest Coverage Ratio (X) | 149.64 | 161.83 | 218.11 | 214.54 | 188.33 |
| Interest Coverage Ratio (Post Tax) (X) | 105.31 | 104.49 | 139.91 | 134.68 | 100.36 |
| Enterprise Value (Cr.) | 20293.77 | 21146.70 | 20763.57 | 16203.61 | 9597.83 |
| EV / Net Operating Revenue (X) | 6.45 | 7.27 | 7.40 | 7.35 | 6.80 |
| EV / EBITDA (X) | 31.62 | 34.49 | 33.84 | 30.87 | 35.37 |
| MarketCap / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| Retention Ratios (%) | 95.79 | 97.12 | 97.11 | 96.55 | -162.63 |
| Price / BV (X) | 7.27 | 8.88 | 10.26 | 9.77 | 7.25 |
| Price / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 |
After reviewing the key financial ratios for Timken India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Cash EPS (Rs.), as of Mar 25, the value is 70.75. This value is within the healthy range. It has increased from 63.46 (Mar 24) to 70.75, marking an increase of 7.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Dividend / Share (Rs.), as of Mar 25, the value is 36.00. This value exceeds the healthy maximum of 3. It has increased from 2.50 (Mar 24) to 36.00, marking an increase of 33.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 418.49. It has increased from 386.81 (Mar 24) to 418.49, marking an increase of 31.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 85.32. This value is within the healthy range. It has increased from 81.52 (Mar 24) to 85.32, marking an increase of 3.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 74.05. This value is within the healthy range. It has increased from 70.19 (Mar 24) to 74.05, marking an increase of 3.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 73.48. This value is within the healthy range. It has increased from 69.69 (Mar 24) to 73.48, marking an increase of 3.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For PBDIT Margin (%), as of Mar 25, the value is 20.38. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 20.38, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 17.69. This value is within the healthy range. It has decreased from 18.14 (Mar 24) to 17.69, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 25, the value is 17.55. This value is within the healthy range. It has decreased from 18.01 (Mar 24) to 17.55, marking a decrease of 0.46.
- For Net Profit Margin (%), as of Mar 25, the value is 14.21. This value exceeds the healthy maximum of 10. It has increased from 13.47 (Mar 24) to 14.21, marking an increase of 0.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.72. This value is within the healthy range. It has decreased from 16.22 (Mar 24) to 15.72, marking a decrease of 0.50.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.11. This value is within the healthy range. It has decreased from 20.99 (Mar 24) to 19.11, marking a decrease of 1.88.
- For Return On Assets (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 13.06, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.05 (Mar 24) to 0.98, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has decreased from 3.91 (Mar 24) to 3.82, marking a decrease of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 2.56. This value exceeds the healthy maximum of 2. It has increased from 2.50 (Mar 24) to 2.56, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.80. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 4.80, marking an increase of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 20. It has increased from 2.87 (Mar 24) to 4.20, marking an increase of 1.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 20. It has increased from 2.36 (Mar 24) to 3.53, marking an increase of 1.17.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.80. This value exceeds the healthy maximum of 70. It has decreased from 97.13 (Mar 24) to 95.80, marking a decrease of 1.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.47. This value exceeds the healthy maximum of 70. It has decreased from 97.64 (Mar 24) to 96.47, marking a decrease of 1.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 149.64. This value is within the healthy range. It has decreased from 161.83 (Mar 24) to 149.64, marking a decrease of 12.19.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 105.31. This value is within the healthy range. It has increased from 104.49 (Mar 24) to 105.31, marking an increase of 0.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,293.77. It has decreased from 21,146.70 (Mar 24) to 20,293.77, marking a decrease of 852.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.45. This value exceeds the healthy maximum of 3. It has decreased from 7.27 (Mar 24) to 6.45, marking a decrease of 0.82.
- For EV / EBITDA (X), as of Mar 25, the value is 31.62. This value exceeds the healthy maximum of 15. It has decreased from 34.49 (Mar 24) to 31.62, marking a decrease of 2.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For Retention Ratios (%), as of Mar 25, the value is 95.79. This value exceeds the healthy maximum of 70. It has decreased from 97.12 (Mar 24) to 95.79, marking a decrease of 1.33.
- For Price / BV (X), as of Mar 25, the value is 7.27. This value exceeds the healthy maximum of 3. It has decreased from 8.88 (Mar 24) to 7.27, marking a decrease of 1.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Timken India Ltd:
- Net Profit Margin: 14.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.11% (Industry Average ROCE: 29.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.72% (Industry Average ROE: 80.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 105.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 49.4 (Industry average Stock P/E: 29.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Bearings | No. 39-42, Electronic City, Phase II, Hosur Road, Bengaluru Karnataka 560100 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Koul | Chairman & Managing Director |
| Mr. Avishrant Keshava | Whole Time Director |
| Mr. Ajay Sood | Independent Director |
| Mr. George J Ollapally | Independent Director |
| Dr. Lakshmi Lingam | Independent Director |
| Mrs. Soumitra Hazra | Independent Director |
| Mr. Douglas Smith | Director |
| Mr. Hansal Patel | Director |
FAQ
What is the intrinsic value of Timken India Ltd?
Timken India Ltd's intrinsic value (as of 27 December 2025) is 2502.04 which is 16.26% lower the current market price of 2,988.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 22,475 Cr. market cap, FY2025-2026 high/low of 3,576/2,200, reserves of ₹2,693 Cr, and liabilities of 3,382 Cr.
What is the Market Cap of Timken India Ltd?
The Market Cap of Timken India Ltd is 22,475 Cr..
What is the current Stock Price of Timken India Ltd as on 27 December 2025?
The current stock price of Timken India Ltd as on 27 December 2025 is 2,988.
What is the High / Low of Timken India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Timken India Ltd stocks is 3,576/2,200.
What is the Stock P/E of Timken India Ltd?
The Stock P/E of Timken India Ltd is 49.4.
What is the Book Value of Timken India Ltd?
The Book Value of Timken India Ltd is 368.
What is the Dividend Yield of Timken India Ltd?
The Dividend Yield of Timken India Ltd is 1.20 %.
What is the ROCE of Timken India Ltd?
The ROCE of Timken India Ltd is 20.9 %.
What is the ROE of Timken India Ltd?
The ROE of Timken India Ltd is 17.0 %.
What is the Face Value of Timken India Ltd?
The Face Value of Timken India Ltd is 10.0.